BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 25354177)

  • 1. Nano-sized platforms for vaginal drug delivery.
    El-Hammadi MM; Arias JL
    Curr Pharm Des; 2015; 21(12):1633-44. PubMed ID: 25354177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanocarriers For Vaginal Drug Delivery.
    Iqbal Z; Dilnawaz F
    Recent Pat Drug Deliv Formul; 2019; 13(1):3-15. PubMed ID: 30767755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring novel approaches to vaginal drug delivery.
    Gupta S; Gabrani R; Ali J; Dang S
    Recent Pat Drug Deliv Formul; 2011 May; 5(2):82-94. PubMed ID: 21413924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymer-based nanocarriers for vaginal drug delivery.
    das Neves J; Nunes R; Machado A; Sarmento B
    Adv Drug Deliv Rev; 2015 Sep; 92():53-70. PubMed ID: 25550217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The vagina as a route for systemic drug delivery.
    Hussain A; Ahsan F
    J Control Release; 2005 Mar; 103(2):301-13. PubMed ID: 15763615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnology-Based Platforms for Vaginal Delivery of Peptide Microbicides.
    Sánchez-López E; Gómara MJ; Haro I
    Curr Med Chem; 2021; 28(22):4356-4379. PubMed ID: 33297908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and in vivo safety assessment of tenofovir-loaded nanoparticles-in-film as a novel vaginal microbicide delivery system.
    Machado A; Cunha-Reis C; Araújo F; Nunes R; Seabra V; Ferreira D; das Neves J; Sarmento B
    Acta Biomater; 2016 Oct; 44():332-40. PubMed ID: 27544812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfonate-modified phenylboronic acid-rich nanoparticles as a novel mucoadhesive drug delivery system for vaginal administration of protein therapeutics: improved stability, mucin-dependent release and effective intravaginal placement.
    Li C; Huang Z; Liu Z; Ci L; Liu Z; Liu Y; Yan X; Lu W
    Int J Nanomedicine; 2016; 11():5917-5930. PubMed ID: 27877038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal drug delivery: strategies and concerns in polymeric nanoparticle development.
    Wong TW; Dhanawat M; Rathbone MJ
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1419-34. PubMed ID: 24960192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging Trends and Potential Prospects in Vaginal Drug Delivery.
    Mahant S; Sharma AK; Gandhi H; Wadhwa R; Dua K; Kapoor DN
    Curr Drug Deliv; 2023; 20(6):730-751. PubMed ID: 35422213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approaches in Polymeric Nanoparticles for Vaginal Drug Delivery: A Review of the State of the Art.
    Leyva-Gómez G; Piñón-Segundo E; Mendoza-Muñoz N; Zambrano-Zaragoza ML; Mendoza-Elvira S; Quintanar-Guerrero D
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29882846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug delivery by the intravaginal route.
    Woolfson AD; Malcolm RK; Gallagher R
    Crit Rev Ther Drug Carrier Syst; 2000; 17(5):509-55. PubMed ID: 11108158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating Nanomedicines: Obstacles and Advancements.
    Swierczewska M; Crist RM; McNeil SE
    Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovations in bioadhesive vaginal drug delivery system.
    Bassi P; Kaur G
    Expert Opin Ther Pat; 2012 Sep; 22(9):1019-32. PubMed ID: 22860765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances on anti-HIV vaginal delivery systems development.
    Antimisiaris SG; Mourtas S
    Adv Drug Deliv Rev; 2015 Sep; 92():123-45. PubMed ID: 25858666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal Drug Delivery Systems to Control Microbe-Associated Infections.
    Xie L; Li Y; Liu Y; Chai Z; Ding Y; Shi L; Wang J
    ACS Appl Bio Mater; 2023 Sep; 6(9):3504-3515. PubMed ID: 36932958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravaginal gels as drug delivery systems.
    Justin-Temu M; Damian F; Kinget R; Van Den Mooter G
    J Womens Health (Larchmt); 2004 Sep; 13(7):834-44. PubMed ID: 15385078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why consider vaginal drug administration?
    Alexander NJ; Baker E; Kaptein M; Karck U; Miller L; Zampaglione E
    Fertil Steril; 2004 Jul; 82(1):1-12. PubMed ID: 15236978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymeric gels for intravaginal drug delivery.
    Cook MT; Brown MB
    J Control Release; 2018 Jan; 270():145-157. PubMed ID: 29223536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent trends of nanomedicinal approaches in clinics.
    Dilnawaz F; Acharya S; Sahoo SK
    Int J Pharm; 2018 Mar; 538(1-2):263-278. PubMed ID: 29339248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.